Compile Data Set for Download or QSAR
Report error Found 84 Enz. Inhib. hit(s) with all data for entry = 9137
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444781(US10662189, Compound WX032)
Affinity DataIC50: 0.234nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444767(US10662189, Compound WX018)
Affinity DataIC50: 0.391nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444822(US10662189, Compound WX073)
Affinity DataIC50: 0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444825(US10662189, Compound WX076)
Affinity DataIC50: 0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444827(US10662189, Compound WX078)
Affinity DataIC50: 0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444765(US10662189, Compound WX016)
Affinity DataIC50: 0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444763(US10662189, Compound WX014)
Affinity DataIC50: 0.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444779(US10662189, Compound WX030)
Affinity DataIC50: 0.515nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444812(US10662189, Compound WX063)
Affinity DataIC50: 0.560nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444766(US10662189, Compound WX017)
Affinity DataIC50: 0.641nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444782(US10662189, Compound WX033)
Affinity DataIC50: 0.671nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444812(US10662189, Compound WX063)
Affinity DataIC50: 0.685nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444820(US10662189, Compound WX071)
Affinity DataIC50: 0.740nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444755(US10662189, Compound WX009 | US10662189, Compound ...)
Affinity DataIC50: 0.860nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444780(US10662189, Compound WX031)
Affinity DataIC50: 0.861nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444810(US10662189, Compound WX061)
Affinity DataIC50: 0.989nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444762(US10662189, Compound WX013)
Affinity DataIC50: 0.994nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444826(US10662189, Compound WX077)
Affinity DataIC50: 1.01nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444823(US10662189, Compound WX074)
Affinity DataIC50: 1.03nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444764(US10662189, Compound WX015)
Affinity DataIC50: 1.04nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444806(US10662189, Compound WX057)
Affinity DataIC50: 1.25nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444802(US10662189, Compound WX053)
Affinity DataIC50: 1.49nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444755(US10662189, Compound WX009 | US10662189, Compound ...)
Affinity DataIC50: 1.80nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444814(US10662189, Compound WX065)
Affinity DataIC50: 1.87nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444807(US10662189, Compound WX058)
Affinity DataIC50: 1.99nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444808(US10662189, Compound WX059)
Affinity DataIC50: 2.02nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444813(US10662189, Compound WX064)
Affinity DataIC50: 2.23nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444817(US10662189, Compound WX068)
Affinity DataIC50: 2.24nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444815(US10662189, Compound WX066)
Affinity DataIC50: 2.48nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444792(US10662189, Compound WX043)
Affinity DataIC50: 2.53nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444759(US10662189, Compound WX010)
Affinity DataIC50: 2.60nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444773(US10662189, Compound WX024)
Affinity DataIC50: 2.70nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444756(US10662189, Compound WX007)
Affinity DataIC50: 2.81nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444768(US10662189, Compound WX019)
Affinity DataIC50: 3.38nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444760(US10662189, Compound WX011)
Affinity DataIC50: 3.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444806(US10662189, Compound WX057)
Affinity DataIC50: 3.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444805(US10662189, Compound WX056)
Affinity DataIC50: 3.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444809(US10662189, Compound WX060)
Affinity DataIC50: 3.48nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444811(US10662189, Compound WX062)
Affinity DataIC50: 3.5nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444815(US10662189, Compound WX066)
Affinity DataIC50: 3.80nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444761(US10662189, Compound WX012)
Affinity DataIC50: 3.90nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444775(US10662189, Compound WX026)
Affinity DataIC50: 4.51nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444757(US10662189, Compound WX008)
Affinity DataIC50: 4.89nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444735(US10662189, Compound WX005)
Affinity DataIC50: 5.03nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444783(US10662189, Compound WX034)
Affinity DataIC50: 5.18nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444824(US10662189, Compound WX075)
Affinity DataIC50: 5.39nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444791(US10662189, Compound WX042)
Affinity DataIC50: 5.42nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444675(US10662189, Compound WX002)
Affinity DataIC50: 5.66nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444785(US10662189, Compound WX036)
Affinity DataIC50: 6.27nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4B(Human)
Shijiazhuang Sagacity New Drug Development

US Patent
LigandPNGBDBM444816(US10662189, Compound WX067)
Affinity DataIC50: 6.40nMAssay Description:The enzyme activity was indicated by measuring the AMP/GMP expression and tracing AMP/GMP antibody binding based on fluorescence polarization in the ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2021
Entry Details
Go to US Patent

Displayed 1 to 50 (of 84 total ) | Next | Last >>
Jump to: